Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
45.40%
60%
—
—
60%
—
5 Years
Score—
Net Growth45.40%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev Trend60%
Revenue Consistency—
Prelude Therapeutics Inc fundamental performance
Across Prelude Therapeutics Inc's full reported history, from 2020 to 2025, revenue grew from $ 0.00 to $ 12M and net income went from -$ 56M to -$ 99M. Revenue increased in 50% of the years measured; net income in 50%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 5.36 | — |
1 Year2025-08-13 | $ 0.91 | 490.96% |
5 Years2021-08-13 | $ 32.17 | -83.34% |
All Time2020-09-25 | $ 26.20 | -79.54% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | All Time2020-09-25 |
|---|---|---|---|---|
| Price | $ 5.36 | $ 0.91 | $ 32.17 | $ 26.20 |
| Return | — | 490.96% | -83.34% | -79.54% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 22M | -$ 60M | $ 151M |
| 2025 | $ 12M | -$ 99M | $ 103M |
| 2024 | $ 7M | -$ 127M | $ 133M |
| 2023 | $ 0.00 | -$ 121M | $ 232M |
| 2022 | $ 0.00 | -$ 107M | $ 201M |
| 2021 | $ 0.00 | -$ 110M | $ 291M |
| IPO2020 | $ 0.00 | -$ 56M | $ 218M |
Explore beyond PRLD
You're looking at Prelude Therapeutics Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
